Venrock Healthcare Capital Partners EG, L.P.'s Net Worth
$0
Estimate Recalculated Sep 11, 2024 03:36PM EST
Who is Venrock Healthcare Capital Partners EG, L.P.?
Venrock Healthcare Capital Partners EG, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include KalVista Pharmaceuticals, Inc., Tricida, Inc., and Vistagen Therapeutics, Inc..
SEC CIK
Venrock Healthcare Capital Partners EG, L.P.'s CIK is 0001808512
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Tricida, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -63.23% | -6.45M |
$0.54 | -$3,501,546.58 | 3.75M |
Oct 24 - Oct 26
| |||
Form 4
| +3.57% | 351.87K |
$10.68 | $3,756,273.14 | 10.2M |
Oct 18 - Oct 19
| |||
Form 4
| +1.81% | 174.97K |
$11.68 | $2,043,302.16 | 9.85M |
Oct 13 - Oct 17
| |||
Form 4
| +1.41% | 134.21K |
$11.91 | $1,597,983.46 | 9.68M |
Oct 7 - Oct 11
| |||
Form 4
| +2.39% | 223.1K |
$11.81 | $2,634,811.00 | 9.54M |
Oct 4
| |||
Form 4
| +4.92% | 436.92K |
$10.75 | $4,697,069.76 | 9.32M |
Sep 29 - Oct 3
| |||
Form 4
| +7.08% | 587.21K |
$8.90 | $5,225,027.84 | 8.88M |
Sep 26 - Sep 28
| |||
Form 4
| +9.03% | 686.71K |
$11.53 | $7,918,744.29 | 8.29M |
Sep 2 - Sep 7
| |||
Form 4
| +0.66% | 50K |
$12.20 | $610,000.00 | 7.61M |
Aug 30
| |||
Form 4
| +0.25% | 18.9K |
$9.21 | $174,069.00 | 7.56M |
Jul 29
| |||
Form 4
| +0.99% | 74.2K |
$9.26 | $687,181.05 | 7.54M |
Jul 21 - Jul 25
| |||
Form 4
| +2.05% | 150K |
$9.18 | $1,377,250.00 | 7.46M |
Jul 18 - Jul 20
| |||
Form 4
| +1.31% | 94.57K |
$9.88 | $934,815.33 | 7.31M |
Jul 12 - Jul 14
| |||
Form 4
| +1.24% | 88.2K |
$9.61 | $847,230.00 | 7.22M |
Jul 1 - Jul 5
| |||
Form 4
| +0.89% | 62.87K |
$9.76 | $613,509.92 | 7.13M |
Jun 28 - Jun 30
| |||
Form 4
| +7.48% | 492.02K |
$10.37 | $5,101,091.60 | 7.07M |
Jun 22 - Jun 24
| |||
Form 4
| +0.09% | 5.95K |
$9.69 | $57,665.19 | 6.58M |
Jun 16
| |||
Form 4
| +1.83% | 118.05K |
$8.57 | $1,011,461.14 | 6.57M |
Jun 10 - Jun 14
| |||
Form 4
| +10.03% | 588.02K |
$9.65 | $5,672,963.18 | 6.45M |
Jun 7 - Jun 9
| |||
Form 4
| +3.36% | 190.87K |
$9.16 | $1,748,709.45 | 5.87M |
Jun 2 - Jun 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Vistagen Therapeutics, Inc. (VTGN) Snapshot price: $3.41
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.29% | -60.00K |
$0.89 | -$53,400.00 | 20.64M |
Jul 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
KalVista Pharmaceuticals, Inc. (KALV) Snapshot price: $12.34
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 20
| |||
Form 4
| +1.82% | 86.05K |
$14.62 | $1,257,828.78 | 4.82M |
Feb 6 - Feb 8
| |||
Form 4
| +1.89% | 88.1K |
$14.47 | $1,274,792.53 | 4.74M |
Jan 30
| |||
Form 4
| +2.01% | 91.8K |
$14.05 | $1,289,802.42 | 4.65M |
Jan 25 - Jan 29
| |||
Form 4
| +2.22% | 99.13K |
$12.53 | $1,241,684.52 | 4.56M |
Jan 22 - Jan 24
| |||
Form 4
| +3.33% | 143.6K |
$12.55 | $1,801,601.80 | 4.46M |
Jan 17 - Jan 19
| |||
Form 4
| +0.61% | 26.25K |
$12.72 | $333,779.23 | 4.32M |
Jan 11 - Jan 16
| |||
Form 4
| +3.32% | 137.7K |
$12.54 | $1,726,456.92 | 4.29M |
Jan 8 - Jan 10
| |||
Form 4
| +1.45% | 59.37K |
$12.14 | $720,543.04 | 4.15M |
Jan 3 - Jan 4
| |||
Form 4
| +14.52% | 519.02K |
$12.46 | $6,465,649.95 | 4.09M |
Dec 27 - Dec 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |